Your browser doesn't support javascript.
loading
Research progress of SARS-CoV-2 main protease inhibitors / 药学学报
Acta Pharmaceutica Sinica ; (12): 2581-2600, 2023.
Article em Zh | WPRIM | ID: wpr-999009
Biblioteca responsável: WPRO
ABSTRACT
As a common protease with high similarity among coronavirus species, the main protease (Mpro) of SARS-CoV-2 is responsible for the catalytic hydrolysis of viral precursor proteins into functional proteins, which is essential for coronavirus replication and is one of the ideal targets for the development of broad-spectrum antiviral drugs. This paper reviews the main protease inhibitors of SARS-CoV-2, including their molecular structures, potencies and drug-like profiles, binding modes and structure-activity relationships, etc.
Palavras-chave
Texto completo: 1 Base de dados: WPRIM Idioma: Zh Revista: Acta Pharmaceutica Sinica Ano de publicação: 2023 Tipo de documento: Article País de publicação: CHINA / CN / REPUBLIC OF CHINA
Texto completo: 1 Base de dados: WPRIM Idioma: Zh Revista: Acta Pharmaceutica Sinica Ano de publicação: 2023 Tipo de documento: Article País de publicação: CHINA / CN / REPUBLIC OF CHINA